• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受慢性血管紧张素II阻滞剂治疗的儿科患者术后持续性血管麻痹

Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.

作者信息

Pandya Nischal R, Alphonso Nelson, Tu Quyen, Venugopal Prem, Schlapbach Luregn J

机构信息

Pediatric Cardiac Surgery, Lady Cilento Children's Hospital, Brisbane, QLD, Australia.

Mater Research Institute, The University of Queensland, Brisbane, QLD, Australia.

出版信息

Front Cardiovasc Med. 2018 Sep 4;5:121. doi: 10.3389/fcvm.2018.00121. eCollection 2018.

DOI:10.3389/fcvm.2018.00121
PMID:30234130
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6131193/
Abstract

Prolonged postoperative vasoplegia is known to occur following cardiac surgery in patients on chronic angiotensin II receptor blocker (ARB) treatment in adults. The perioperative management of these drugs in the pediatric population is not well described and here we would like to highlight this fact. While ARBs are increasingly used in children and adolescents with hypertension, there is lack of data to guide optimal pre-surgical management in the pediatric age group. We report two cases of prolonged vasoplegia following cardiopulmonary bypass occurring in adolescent patients on chronic ARB therapy and the importance of cessation of these drugs preoperatively.

摘要

已知在接受慢性血管紧张素 II 受体阻滞剂(ARB)治疗的成年患者进行心脏手术后会出现术后持续性血管麻痹。这些药物在儿科患者围手术期的管理尚无充分描述,在此我们想强调这一事实。虽然 ARB 在患有高血压的儿童和青少年中使用越来越多,但缺乏数据来指导该年龄组的最佳术前管理。我们报告了两例在接受慢性 ARB 治疗的青少年患者体外循环后出现持续性血管麻痹的病例,以及术前停用这些药物的重要性。

相似文献

1
Prolonged Postoperative Vasoplegia in Pediatric Patients on Chronic Angiotensin II Blocker Treatment.接受慢性血管紧张素II阻滞剂治疗的儿科患者术后持续性血管麻痹
Front Cardiovasc Med. 2018 Sep 4;5:121. doi: 10.3389/fcvm.2018.00121. eCollection 2018.
2
[Factors involved in the development of vasoplegia after cardiac surgery with extracorporeal circulation. A prospective observational study].[体外循环心脏手术后血管麻痹发生的相关因素。一项前瞻性观察研究]
Rev Esp Anestesiol Reanim. 2014 May;61(5):246-53. doi: 10.1016/j.redar.2013.11.015. Epub 2014 Feb 5.
3
Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.术前使用血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂对接受体外循环的儿科患者血流动力学变量的影响。
World J Pediatr Congenit Heart Surg. 2014 Oct;5(4):515-21. doi: 10.1177/2150135114549748.
4
Low systemic vascular resistance after cardiopulmonary bypass: incidence, etiology, and clinical importance.体外循环后低体循环血管阻力:发生率、病因及临床意义。
J Card Surg. 2000 Sep-Oct;15(5):347-53. doi: 10.1111/j.1540-8191.2000.tb00470.x.
5
A Systematic Review of Outcomes Associated With Withholding or Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Before Noncardiac Surgery.在非心脏手术前停用或继续使用血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂相关结局的系统评价。
Anesth Analg. 2018 Sep;127(3):678-687. doi: 10.1213/ANE.0000000000002837.
6
Risk assessment and outcomes of vasoplegia after cardiac surgery.心脏手术后血管麻痹的风险评估及结果
Gen Thorac Cardiovasc Surg. 2017 Oct;65(10):557-565. doi: 10.1007/s11748-017-0789-6. Epub 2017 Jun 13.
7
Vitamin D and Postoperative Vasopressor Use in Cardiopulmonary Bypass.维生素D与体外循环术后血管升压药的使用
Clin Appl Thromb Hemost. 2018 Nov;24(8):1322-1326. doi: 10.1177/1076029618772357. Epub 2018 May 6.
8
Synthetic Human Angiotensin II for Postcardiopulmonary Bypass Vasoplegic Shock.用于体外循环后血管麻痹性休克的合成人血管紧张素II
J Cardiothorac Vasc Anesth. 2019 Nov;33(11):3080-3084. doi: 10.1053/j.jvca.2019.03.004. Epub 2019 Mar 8.
9
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III.术前使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂对心脏手术后房颤发生率的影响:来自房颤抑制试验II和III的队列研究
Eur J Cardiothorac Surg. 2007 May;31(5):817-20. doi: 10.1016/j.ejcts.2007.02.010. Epub 2007 Mar 12.
10
Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.心血管手术后的血管麻痹——病理生理学与靶向治疗
J Cardiothorac Vasc Anesth. 2018 Apr;32(2):1013-1022. doi: 10.1053/j.jvca.2017.10.032. Epub 2017 Oct 27.

引用本文的文献

1
Retrospective Review of Intraoperative Hypotension and Perioperative Angiotensin Inhibitor Use in Pediatrics.儿科术中低血压与围手术期血管紧张素抑制剂使用的回顾性研究
Paediatr Anaesth. 2025 Oct;35(10):848-855. doi: 10.1111/pan.70004. Epub 2025 Jun 27.

本文引用的文献

1
2017 EACTS Guidelines on perioperative medication in adult cardiac surgery.2017年欧洲心胸外科学会成人心脏手术围手术期用药指南。
Eur J Cardiothorac Surg. 2018 Jan 1;53(1):5-33. doi: 10.1093/ejcts/ezx314.
2
Angiotensin II for the Treatment of Vasodilatory Shock.血管扩张性休克的血管紧张素 II 治疗。
N Engl J Med. 2017 Aug 3;377(5):419-430. doi: 10.1056/NEJMoa1704154. Epub 2017 May 21.
3
Withholding versus Continuing Angiotensin-converting Enzyme Inhibitors or Angiotensin II Receptor Blockers before Noncardiac Surgery: An Analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN Prospective Cohort.非心脏手术前停用与继续使用血管紧张素转换酶抑制剂或血管紧张素II受体阻滞剂:非心脏手术患者队列评估前瞻性队列中的血管事件分析
Anesthesiology. 2017 Jan;126(1):16-27. doi: 10.1097/ALN.0000000000001404.
4
Con: ACE Inhibitors Should Be Stopped Prior to Cardiovascular Surgery.反对观点:血管紧张素转换酶抑制剂应在心血管手术前停用。
J Cardiothorac Vasc Anesth. 2016 Jun;30(3):820-2. doi: 10.1053/j.jvca.2016.01.016. Epub 2016 Jan 12.
5
The Use and Misuse of ACE Inhibitors in Patients with Single Ventricle Physiology.单心室生理患者中血管紧张素转换酶抑制剂的使用与误用
Heart Lung Circ. 2016 Mar;25(3):229-36. doi: 10.1016/j.hlc.2015.10.005. Epub 2015 Oct 27.
6
Effect of preoperative angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker use on hemodynamic variables in pediatric patients undergoing cardiopulmonary bypass.术前使用血管紧张素转换酶抑制剂和血管紧张素II受体阻滞剂对接受体外循环的儿科患者血流动力学变量的影响。
World J Pediatr Congenit Heart Surg. 2014 Oct;5(4):515-21. doi: 10.1177/2150135114549748.
7
Efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive children aged 6 to 17 years.坎地沙坦酯在6至17岁高血压儿童中的疗效、安全性及药代动力学
J Clin Hypertens (Greenwich). 2008 Oct;10(10):743-50. doi: 10.1111/j.1751-7176.2008.00022.x.
8
Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension.欧洲主要市场儿科人群使用血管紧张素受体阻滞剂治疗原发性高血压的情况评估。
J Hum Hypertens. 2009 Jun;23(6):420-5. doi: 10.1038/jhh.2008.139. Epub 2008 Dec 4.
9
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.马凡综合征中的血管紧张素 II 阻断与主动脉根部扩张
N Engl J Med. 2008 Jun 26;358(26):2787-95. doi: 10.1056/NEJMoa0706585.
10
Pharmacokinetics of candesartan cilexetil in patients with renal or hepatic impairment.坎地沙坦酯在肾或肝功能损害患者中的药代动力学。
J Hum Hypertens. 1997 Sep;11 Suppl 2:S37-42.